Journals / Türk Kardiyoloji Derneği Arşivi / 2004 / Cilt: 32 - Sayı: 1

Value of serum gamma glutamyltransferase as a cardiovascular risk factor in Turkish adults: A good marker of metabolic syndrome and its components and coronary disease likelihood

Türk erişkinlerinde kalp-damar risk faktörü olarak gama glutamiltransferaz: Metabolik sendrom ve öğelerinin güçlü bir belirteci, koroner hastalık riski için bir gösterge

Pages
1–9
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In 421 men and 447 women (mean age 52.7±11 years), geometric means of GGT were 28.7±1.8 U/L and 20,8±1.8 U/L, respectively (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose of the study was to investigate the value of serum gamma glutamyltransferase (GGT) activity as a cardiovascular risk factor in a population sample of 868 men and women among the cohort of the Turkish Adult Risk Factor Study, surveyed in 2003.
📊
Key Findings & Data:MS was observed in 37%, CHD in 10.5% of the study sample.
💡
Conclusion & Impact:In 421 men and 447 women (mean age 52.7±11 years), geometric means of GGT were 28.7±1.8 U/L and 20,8±1.8 U/L, respectively (p
🔬Design:Survey & Empirical Study
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose of the study was to investigate the value of serum gamma glutamyltransferase (GGT) activity as a cardiovascular risk factor in a population sample of 868 men and women among the cohort of the Turkish Adult Risk Factor Study, surveyed in 2003. Metabolic syndrome (MS) was diagnosed based on criteria of the ATP-III, and coronary heart disease (CHD) on the presence of angina and Minnesota coding of the resting ECGs. MS was observed in 37%, CHD in 10.5% of the study sample. GGT activity was measured by the Elecsys method, and values were log-transformed due to the skewed distribution. In 421 men and 447 women (mean age 52.7±11 years), geometric means of GGT were 28.7±1.8 U/L and 20,8±1.8 U/L, respectively (p

Özet

TEKHARF Çalışmasının temelde Marmara ve İç Anadolu bölgelerinde oturan eski ve yeni kohortundan 868 kişide, başka muayene ve tahliller bağlamında, serum gama glutamiltransferaz (GGT) belirlendi. Amaç, halkımızda GGT'nin kardiyovasküler risk faktörleri, metabolik sendrom (MS) ve koroner kalp hastalığı (KKH) ile ilişkisini incelemekti. MS tanısı ATP-III kriterlerine, KKH tanısı anamnezde angina varlığı ve 12-derivasyonlu istirahat EKG'ının Minnesota kodlamasına dayanılarak kondu. Örneklemin %37'sinde MS, %10.5'unda KKH mevcuttu. Serumda GGT Elecsys metoduyla ölçüldü; değerler normal dağılım sergilemediğinden analizler log-transformasyon suretiyle bildirildi.Yaş ortalaması 52,7±11 olan 421 erkek ve 447 kadında geometrik ortalama değer sırasıyla 28.7±1.8 U/Lve 20,8±1.8 U/L bulundu (p

🔖

Cite This Article

TÜRKMEN, S., ONAT, A., YAZICI, M., CAN, G., SARI, İ., HERGENÇ, G., UZUNLAR, B., UYAREL, H., SANSOY, V., KELEŞ, İ. (2022). Value of serum gamma glutamyltransferase as a cardiovascular risk factor in Turkish adults: A good marker of metabolic syndrome and its components and coronary disease likelihood. Türk Kardiyoloji Derneği Arşivi, Cilt: 32 - Sayı: 1, 1–9. https://ajindex.com/articles/633826

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Conigrave KM, Saunders JB, Reznik RB, Whitfield JB: Prediction of alcohol-related harm by laboratory test results. Clin Chem 1993; 39:2266-70 2. Wannamethee G, Ebrahim S, Shaper AG: Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142:699-708 3. Lee DH, Ha MH, Kim JR, Gross M, Jacobs DR Jr: Gamma-glutamyltransferase, alcohol, and blood pressure: a four year follow-up study. Ann Epidemiol 2002; 12:90-6 4. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K: Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003; 254:287-95 5. Perry IJ, Wannamethee G, Shaper AG: Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21:732-7 6. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M: Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49:1358-66 7. Miura K, Nakagawa H, Nakamura H, Tabata M, Nagase H, Yoshida M, et al: Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers. J Hum Hypertens 1994; 8:445-9 8. Emdin M, Passino C, Michelassi C, Titta F, L'Abbate A, Donato L, Pompella A, Paolicchi A: Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001; 22:1802-7 9. Karlson BW, Wiklund O, Hallgren P, Sjölin M, Lindqvist J, Herlitz J: Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 2000; 247:449-56 10. Paolicchi A, Minotti G, Tonarelli P, et al: Gamma-glutamyltranspeptidase-dependent iron reduction and LDL oxidation: a potential mechanism in atherosclerosis. J Invest Med 1999; 47:151-60 11. Onat A, Sansoy V: Halkımızda koroner hastalığın başsuçlusu metabolik sendrom: koroner risk ile ilişkisi ve yüksek risk kriterleri. Türk Kardiyol Dern Arş 2002; 30; 8-15 12. Onat A, Ceyhan K, Başar Ö, Erer B, Toprak S, Sansoy V: Metabolic syndrome: major impact on coronary risk in a population with low choleterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165:285-92 13. Friedewald WT, Levy J, Fredrickson DS: Estimation of the concentration of low-density-lipoprotein choleste